NEW YORK ( TheStreet) -- Shares of China-biotics (Nasdaq: CHBT) were gapping down Thursday morning with an open price 11.6% lower than Wednesday's closing price. The stock closed at $2.85 Wednesday and opened today's trading at $2.52. The average volume for China-biotics has been 776,600 shares per day over the past 30 days. China-biotics has a market cap of $76.6 million and is part of the health care sector and drugs industry. Shares are down 87.8% year to date as of the close of trading on Wednesday. China-Biotics, Inc. engages in the research, development, production, marketing, and distribution of probiotics products in the People's Republic of China. Its products contain live microbial food supplements, which beneficially affect the host by improving its intestinal microbial balance. The company has a P/E ratio of 2.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates China-biotics as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and a generally disappointing performance in the stock itself. You can view the full China-biotics Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.